Meeting
2013 ASCO Annual Meeting
Circulating biomarkers in patients receiving neoadjuvant chemotherapy combined with sunitinib for locally advanced breast cancer.
Authors
Ursa Abigail Brown-Glaberman
University of Arizona, Arizona Cancer Center, Tucson, AZ
Ursa Abigail Brown-Glaberman , Jennifer M. Specht , Maria Iannone , Brenda F. Kurland , Robert B. Livingston , Alison Stopeck
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Clinical Trial Registration Number
NCT00513695
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1089)
DOI
10.1200/jco.2013.31.15_suppl.1089
Abstract #
1089
Poster Bd #
24H
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers.
First Author: Sara P. Myers
Poster
2012 Breast Cancer Symposium
Metronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME).
First Author: Vanessa Petry
Poster
2012 ASCO Annual Meeting
Correlation between miRNA (miR) and gene expression profiles (GEP) and response to neoadjuvant chemotherapy (NT) in patients with locally advanced and inflammatory breast cancer (BC).
First Author: Sierra Mi Li
Poster
2011 ASCO Annual Meeting
Correlation between miRNA and gene expression profiles and response to neoadjuvant chemotherapy in patients with locally advanced and inflammatory breast cancer.
First Author: G. Somlo